Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear. - Suppr | 超能文献

Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.

作者信息

Windsor Alastair C J, Cohen Richard, Jiao Long R, Stebbing Justin

出版信息

Future Oncol. 2008 Dec;4(6):741-4. doi: 10.2217/14796694.4.6.741.

DOI:10.2217/14796694.4.6.741

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.

Future Oncol. 2008 Dec;4(6):741-4. doi: 10.2217/14796694.4.6.741.

2

The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.在一名转移性结直肠癌患者中，在基于奥沙利铂的化疗后使用西妥昔单抗。

Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):4-7.

3

Cetuximab in metastatic colorectal cancer.西妥昔单抗用于转移性结直肠癌

Lancet Oncol. 2010 Apr;11(4):313-4; author reply 314. doi: 10.1016/S1470-2045(10)70019-X.

4

Cetuximab therapy in the treatment of metastatic colorectal cancer: the future frontier?西妥昔单抗治疗转移性结直肠癌：未来的前沿？

Int J Surg. 2013;11(7):507-13. doi: 10.1016/j.ijsu.2013.04.014. Epub 2013 May 6.

5

Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?用血管内皮生长因子单克隆抗体治疗转移性结直肠癌：转移部位会产生影响吗？

J Clin Oncol. 2003 Sep 15;21(18):3542-3; author reply 3543. doi: 10.1200/JCO.2003.99.057.

6

Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.

J Vasc Interv Radiol. 2007 Dec;18(12):1588-91. doi: 10.1016/j.jvir.2007.08.015.

7

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.西妥昔单抗治疗转移性结直肠癌期间出现的睫毛粗长症和睫毛变白症

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11.

8

[The results of cetuximab treatment of a patient with multiple pretreated, irinotecan resistant metastatic colorectal cancer].[西妥昔单抗治疗一名经多次预处理且对伊立替康耐药的转移性结直肠癌患者的结果]

Magy Onkol. 2005;49(4):337-42. Epub 2006 Mar 6.

9

Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.优化转移性结直肠癌中基于奥沙利铂的治疗方案。

Clin Adv Hematol Oncol. 2008 May;6(5):360-1.

10

Cetuximab in the treatment of colorectal cancer.西妥昔单抗治疗结直肠癌

Future Oncol. 2005 Apr;1(2):173-81. doi: 10.1517/14796694.1.2.173.

引用本文的文献

1

Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.替西罗莫司通过依赖 CIP2A 的机制增强西妥昔单抗在结肠癌中的疗效。

J Cancer Res Clin Oncol. 2014 Apr;140(4):561-71. doi: 10.1007/s00432-014-1596-4. Epub 2014 Feb 4.

2

Liver abscess after liver metastasectomy is a poor prognostic factor in patients with colorectal cancer.结直肠癌肝转移术后肝脓肿是预后不良的危险因素。

J Gastrointest Surg. 2011 Oct;15(10):1798-806. doi: 10.1007/s11605-011-1642-3. Epub 2011 Jul 23.